<bill session="116" type="h" number="3925" updated="2022-11-01T13:50:27Z">
  <state datetime="2019-07-23">REFERRED</state>
  <status>
    <introduced datetime="2019-07-23"/>
  </status>
  <introduced datetime="2019-07-23"/>
  <titles>
    <title type="display">Reducing Barriers to Substance Use Treatment Act</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to prohibit States receiving Federal medical assistance for medication-assisted treatment under Medicaid from imposing utilization control policies or procedures with respect to such treatment, and for other purposes.</title>
    <title type="short" as="introduced">Reducing Barriers to Substance Use Treatment Act</title>
  </titles>
  <sponsor bioguide_id="T000469"/>
  <cosponsors>
    <cosponsor bioguide_id="M001180" joined="2019-07-23"/>
    <cosponsor bioguide_id="T000483" joined="2019-12-04"/>
  </cosponsors>
  <actions>
    <action datetime="2019-07-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-07-23" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-07-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="5000" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health care coverage and access"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-08-31T21:50:27Z" status="Introduced in House">Reducing Barriers to Substance Use Treatment Act

This bill prohibits state Medicaid programs from imposing any utilization control policies, including prior authorization requirements, with respect to medication-assisted treatment for opioid-use disorders.</summary>
</bill>
